Apart from GBM, SH3GL2 deviation was marked in the kidney chromophobe tumor (KICH), kidney renal cell carcinoma (KIRC), pancreatic adenocarcinoma (PAAD), prostate adenocarcinoma (PRAD), and sarcoma (SARC). The gene discussed is SH3GL2; the disease is sarcoma.